The ninth annual Cocktails & Karaoke fundraising event on Nov. 13 raised $57,000 to benefit chronically ill K-8th grade students at Kunsberg School on the campus of National Jewish Health.
Bruce E. Mosler, Co-Chairman of the Board of Cushman & Wakefield Inc., was the evening’s honoree as he was presented the National Jewish Health® 2010 Humanitarian Award on December 11 during the Real Estate and Construction Industries’ Winter’s Eve Gala at the Grand Hyatt New York. The event raised $1.4 million to establish the Bruce E. and Wendy F. Mosler Fund for Treatment and Research of Pediatric and Adult Asthma.
Her clinical work focuses on sleep issues in children of all ages, including difficulties falling asleep, staying asleep, sleep apnea and sleep terrors. Her research focuses on sleep in children with chronic illnesses and their parents.
Food allergies are more common among people with asthma and may contribute to asthma attacks, according to one of the most comprehensive surveys of food allergies ever undertaken.
Many children, especially those with eczema, are unnecessarily avoiding foods based on incomplete information about potential food-allergies, according to researchers at National Jewish Health. The food avoidance poses a nutritional risk for these children.
National Jewish Health has received a US patent for a new kind of vaccine, which uses a small lipid bubble to deliver an antigen and DNA adjuvant.
The popular annual fundraising event Cocktails & Karaoke will be held Nov. 13 at the retro Curtis Hotel in downtown Denver.
Top Docs were named most often in a survey of more than 7,500 Denver metro-area doctors, who were asked, specialty by specialty, which physicians they would trust to treat them or their families.
Prolonged disruptions in sleep patterns can lead to serious health issues if not addressed. Dr. Mark Aloia offers the following tips for getting your sleep patterns back on track:
Sildenafil failed to significantly increase exercise capacity, but did improve arterial oxygenation, shortness of breath and quality of life in patients with advanced idiopathic pulmonary fibrosis (IPF), in the first randomized trial of the medication for IPF.